Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02404688

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Detailed description

To study the effects of ethanol clamped at BAC 0.04% and THC (1.05 mg in a 70 kg individual) on driving.

Conditions

Interventions

TypeNameDescription
DRUGActive delta-9-THCLow dose (0.015 mg/kg = 1.05 mg in a 70 kg individual) THC, dissolved in alcohol. This dose is roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint". Administered over 20 minutes.
DRUGPlaceboControl: small amount of alcohol (quarter teaspoon), with no THC. Administered over 20 minutes.
DRUGActive EthanolTarget BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes.
DRUGPlaceboControl: no alcohol, administered for a total of 80 minutes.

Timeline

Start date
2015-12-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2015-03-31
Last updated
2025-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02404688. Inclusion in this directory is not an endorsement.